89bio, Inc. (ETNB)

89bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	126.06	316.16	55.26	52.43	98.18
Short-Term Investments	313.9	262.71	132.91	98.29	106.45
Cash & Short-Term Investments	439.96	578.87	188.16	150.72	204.63
Cash Growth	-24.00%	207.65%	24.84%	-26.35%	119.24%
Prepaid Expenses	36.5	14.66	7.92	11.24	5.55
Restricted Cash	-	-	-	0.03	0.03
Total Current Assets	476.45	593.53	196.08	161.98	210.2
Property, Plant & Equipment	1.6	2.34	0.46	0.15	0.17
Other Long-Term Assets	0.64	0.4	0.29	0.29	0.71
Total Assets	478.69	596.27	196.82	162.42	211.07
Accounts Payable	15.38	8.59	12.5	6.84	2.07
Accrued Expenses	20.02	20.53	11.94	10.19	6.05
Current Portion of Long-Term Debt	-	-	-	2.5	-
Current Portion of Leases	0.73	0.5	0.17	-	-
Total Current Liabilities	36.13	29.61	24.61	19.54	8.11
Long-Term Debt	35.73	24.8	20.19	16.9	-
Long-Term Leases	1.09	1.82	0.19	-	-
Other Long-Term Liabilities	4.95	3.74	-	0.03	-
Total Liabilities	77.9	59.96	44.99	36.47	8.11
Common Stock	0.12	0.09	0.05	0.02	0.02
Additional Paid-In Capital	1,225	993.46	467.37	339.22	326.05
Retained Earnings	-824.51	-457.43	-315.24	-213.22	-123.1
Comprehensive Income & Other	0.56	0.19	-0.35	-0.06	-0.01
Total Common Equity	400.79	536.31	151.83	125.96	202.96
Shareholders' Equity	400.79	536.31	151.83	125.96	202.96
Total Liabilities & Equity	478.69	596.27	196.82	162.42	211.07
Total Debt	37.55	27.11	20.55	19.4	-
Net Cash (Debt)	402.41	551.76	167.61	131.32	204.63
Net Cash Growth	-27.07%	229.19%	27.64%	-35.82%	119.24%
Net Cash Per Share	3.84	7.75	4.82	6.53	12.72
Filing Date Shares Outstanding	145.98	93.5	52.23	20.35	19.95
Total Common Shares Outstanding	119.85	93.27	50.56	20.32	19.93
Working Capital	440.32	563.92	171.47	142.45	202.09
Book Value Per Share	3.34	5.75	3.00	6.20	10.18
Tangible Book Value	400.79	536.31	151.83	125.96	202.96
Tangible Book Value Per Share	3.34	5.75	3.00	6.20	10.18

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q